UCL ranked 6th globally for medicine in world rankings
UCL has been placed 6th globally for medicine and 1st for education in the world’s most consulted university ranking.
BRC News
Preterm babies do not habituate to repeated pain
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, a study led by UCL has found.
Population-wide risk scores limited ability to predict disease
Predictive performance of polygenic risk scores is limited, according to a new analysis
UCLH and Crick research influence new national treatment guidelines for COVID-19
Research from UCLH and the Francis Crick Institute has had an important impact on draft NICE guidance.
Flagship NIHR career development award for BRC research leader
Prof Laura Shallcross will lead research to reduce the impact of infections in care homes after being awarded a prestigious NIHR Research Professorship.
UCLH patient first in world to receive a new investigational drug in a phase 1 trial
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
Wearable tech, AI and clinical teams combine to change the face of clinical trial monitoring
A multi-disciplinary team of researchers, involving several UCLH and UCL clinicians and scientists, has developed a way to monitor the progression of movement disorders using motion capture technology and AI.
New precision therapy for bile duct cancer extends patients’ lives
A new personalised cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicentre trial involving researchers at UCL and UCLH.
Short film highlights the need for diversity in health research
A short film produced by the BRC highlights the importance of involving people of all backgrounds and ethnicities in health research.
“We have entered a new era in the treatment of Alzheimer’s disease”
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
Trial of innovative blood cancer treatment expanded
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
First UK proton beam therapy trial for breast cancer launches at UCLH
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
Early phase cancer trials newsletter out now
Read the latest early phase cancer trials newsletter from the NIHR UCLH Clinical Research Facility.
Global team to study international differences in COVID-19 immunity
Researchers at UCLH are part of an international consortium to find out why COVID-19 was milder in some parts of the world.
